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A B S T R A C T
Metabolic parameters were determined in fasting blood serum, fasting first morning
urine, and 24-hour urine of male patients with recurrent calcium oxalate stones (N=26,
age 39.1±6.2 years) as well as in male healthy controls (N=18, age 35.0±7.1 years), rec-
ruited from the eastern part of Croatia. The 24-hour urinary calcium excretion was sig-
nificantly higher (p<0.01) for patients (5.6±2.5 mmol) than for controls (3.7±1.9 mmol),
but potassium excretion was higher (p<0.01) for controls (74.5±33.8 mmol) than for pa-
tients (49.2±15.7 mmol). The mean ionic activity product of calcium and oxalate ions,
IAP(CaOx), calculated from the fasting first morning urine parameters, was 25% hig-
her for patients than for controls, but the difference was not statistically significant
(p>0.05). Very strong correlation (r=0.97) was obtained between IAP(CaOx) values and
calculated Ogawa indices that were recommended for estimating the potential risk for
calcium oxalate stone formation.
Key words: metabolic parameters, urine, calcium oxalate, urolithiasis, hypercalciu-
ria, hyperoxaluria
Introduction
The formation of urinary stones may
be caused by different factors, i.e., meta-
bolic disorders, anatomic abnormalities,
infections, and/or environmental factors.
Risk factors for stone formation also in-
clude1 a positive family history, nutritio-
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nal factors (i.e., excessive intake of animal
proteins, fat, sugar, oxalates, alcohol, caf-
feine, salt, and vitamin D), nutritional
deficiencies (i.e., water, magnesium, cal-
cium, and potassium), lifestyle factors,
and associated diseases (i.e., parathyroid
problems, osteoporosis, gout). Recurrent
stone formation can be expected in about
50 % of patients2. Investigations in the
field of urolithiasis have revealed that
the majority of patients with urolithiasis
had some metabolic disorder3–9. The ex-
tent of the diagnostic procedures for pa-
tients with urolithiasis depends mostly
on the recurrence rate and stone-related
complications.
The major mineral component of cal-
cium containing urinary stones is cal-
cium oxalate monohydrate. The main
risk factors for calcium oxalate urolithia-
sis are high urinary supersaturation (i.e.
high ionic activity product of calcium and
oxalate ions) and/or insufficient amounts
of ions (i.e., magnesium and citrate) and/
or macromolecules (i.e., calcium binding
proteins, glycosaminoglycans, osteoponti-
ne, nephrocalcine-A, etc.) that inhibit
precipitation of calcium oxalates10–13. Re-
cently, a potent inhibitor (molecular mass
between 14.2 and 16.2 kDa), which is clo-
sely associated with a chromophore re-
sembling urobilirubin, was identified and
it was suggested that this compound
could be primarily responsible for high
urinary inhibitory activity14. In addition,
several oxalate specific binding proteins
that could either inhibit or promote nuc-
leation, growth, and aggregation of cal-
cium oxalate crystals, were recently iden-
tified in the human kidney15.
Determination of factors responsible
for the formation of urinary stones is a
prerequisite for efficient medical treat-
ment and prevention of recurrent stone
formation. Typical metabolic disorders
for adult calcium oxalate stone-formers
are urinary hypercalciuria, hyperoxalu-
ria, hypocitraturia, and a low urine volu-
me5–10. More over, hypercalciuria was pre-
dominant cause in pediatric urolithiasis
in Croatia9. The recurrence of calcium ox-
alate stones can be prevented by a high
fluid intake, appropriate diet, and phar-
macological therapy16–18. Recently, phyto-
therapy (treatment with medicinal plants)
was also proposed as a supplement to the
conventional therapy19.
In this paper, the relevant biochemical
parameters, as determined in blood se-
rum and in urines of patients with recur-
rent calcium oxalate urinary stones (26
patients) and healthy individuals (18 con-
trols) from the eastern part of Croatia,
are compared and evaluated. Additional
parameters (activity product of calcium
and oxalate ions, different risk indices)
that could indicate a potential risk for
calcium oxalate stone formation are cal-
culated and correlated. The inhibitory ro-
le of citrate and magnesium ions on cal-
cium oxalate formation is discussed.
Subjects and Methods
The group of patients comprised 26
male stone-formers (mean age 39.1±6.2
years) with recurrent calcium oxalate
urolithiasis. Six patients stated, to the
best of their knowledge, that they have a
family history of stone formation. Urolit-
hiasis was identified by ultrasonography,
abdominal X-rays, and by the history of
stone passage. Three patients had bilate-
ral urolithiasis. All patients had experi-
enced two or more renal colics with spon-
taneous elimination of the stone. Eigh-
teen patients were treated earlier by extra-
corporeal shock wave lithotripsy (ESWL)
or percutaneous nephrolithotomy. At the
time of the study, two patients had symp-
tomatic renal stones. Patients did not re-
ceive medical therapy for stone preven-
tion during the study. The composition of
stones was determined by infrared (IR)
spectrophotometry (Perkin Elmer Spec-
trophotometer, Model 882).
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The control group comprised 18 heal-
thy male subjects (mean age 35.0±7.1
years) recruited from the hospital staff,
who had no history of stone formation or
renal diseases. No additional diagnostic
procedure was performed to confirm that
they did not have renal stones. All sub-
jects gave informed consent to participate
in the study, which was approved by the
Ethical Committee of the Institute for
Medical Research, Zagreb, Croatia.
Estimation of calcium intakes was ba-
sed on two-day records of food consump-
tion prior to urine collection. Daily cal-
cium intakes were calculated using food
composition tables for raw, cooked and lo-
cal dishes20. Recorded intakes were in the
range of recommended daily allowances
according to age and sex, which are valid
in Croatia21.
The fasting blood and fasting first
morning urine samples were collected in
the morning (6 a.m. after 12 hours over-
night fast). During the 24-h urine collec-
tion, the subjects were on their usual diet.
The serum concentrations of creatini-
ne, urea, alkaline phosphatase, calcium,
phosphorus, magnesium, sodium, potas-
sium, chloride, cholesterol, triglycerides,
proteins, and urate were determined by
autoanalyzer (Hitachi 737, Boehringer,
Mannheim, Germany) equipped with ion
selective electrodes.
The urinary concentrations of calcium,
magnesium, phosphorus, urate, creatini-
ne, and citrate22 were determined spec-
trophotometrically (autoanalyzer Hitachi
737) using Boehringer kits, and concen-
tration of oxalate23 using Sigma Diagnos-
tic kit. Urinary pH was determined by
glass/calomel electrode (GK 2401 C) con-
nected to a pH meter (all Radiometer, Co-
penhagen, Denmark), sodium and potas-
sium concentrations by flame photometry
(Instrument Laboratory 943, Italy) and
chloride concentration by coulometric tit-
ration (Chloride Titrator CTM3, Radio-
meter). The urinary concentration of urea
was determined by enzymatic UV method
using glutamate dehydrogenase, and con-
centration of proteins by turbidimetric
method using benzoate chloride. Urinary
infection was detected by microscopical
examination of urinary sediments.
The parameters for the group of pa-
tients and the group of controls were ex-
pressed as mean value ± standard devia-
tion. The statistical significance of diffe-
rences in mean values of parameters for
patients and controls were tested with
the Student’s t-test. Values of p<0.05 were
considered statistically significant. In ad-
dition, the non-parametric Mann-Whit-
ney test was used for comparing urine pa-
rameters in two groups. Contrary to the
parametric t-test, the Mann-Whitney test
does not assume that the difference be-
tween two independent populations is
normally distributed.
The ionic activity product (IAP) of cal-
cium (Ca) and oxalate (Ox) ions calcula-
ted by computer program EQUIL24 from
metabolic parameters determined in fast-
ing first morning urine was defined as
IAP(CaOx) = a(Ca2+)  a(Ox2–) (1)
where a(Ca2+) and a(Ox2–) are ionic activ-
ities of calcium and oxalate, respectively.
Since the chloride ion concentration (im-
portant for the calculation of urinary ionic
strength) was not experimentally deter-
mined, the calculations were performed
in two steps. In the first step, the specia-
tion and the ionic charge balance in the
urine of each subject were calculated by
EQUIL using the experimentally deter-
mined parameters listed in Table 4. The
calculated value of the charge balance
was positive, and so the chloride ion con-
centration was estimated as the equivalent
amount of negatively charged ions requi-
red for charge compensation. In the sec-
ond step, the speciation and IAP(CaOx)
were calculated including the chloride
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concentration as additional input param-
eter.
Three differently defined indices, the
AP(CaOx)-index and CaOx-risk-index
(RI) proposed by Tiselius25–27, as well as
the AP(CaOx)-EQ2-index proposed by
Ogawa28,29 were calculated for each pa-
tient and control from the parameters de-
termined in the fasting urine specimens.
These indices are essentially simplified
estimations of the ionic activity product
values, IAP(CaOx), and they could indi-
cate the risk of calcium oxalate stone for-
mation. Tiselius AP(CaOx)-indices25–27,
defined for different urine collection ti-
mes, require the following five parame-
ters: contents of calcium (Ca), oxalate
(Ox), magnesium (Mg), citrate (Cit), and
total volume (V) determined at corres-
ponding collection time intervals.
The Tiselius AP(CaOx)-index26 for the
6.5-h urinary excretion (the first morning
urine) was defined as
AP(CaOx)-index = 5.632  Ca0.71 
 Ox  Mg–0.14  Cit–0.10  V–1.2 (2)
where the amounts of Ca, Ox, Mg, and Cit
were expressed in mmol, and the urine
volume (V) was expressed in liters.
The Tiselius CaOx-risk-index25 (RI),
which requires the concentration of crea-
tinine (Cre) instead of the urine volume,
was defined as
RI = (Ca/Cre) 0.71  (Ox/Cre) 
 (Mg/Cre) –0.14  (Cit/Cre) –0.10 (3)
where Ca, Ox, Mg, and Cit were expres-
sed in mmol and Cre in mol per liter.
The Ogawa AP(CaOx)-EQ2-index28,29
that requires only four parameters (con-
centrations of Ca, Ox, Mg, and Cit), was
defined as
AP(CaOx)-EQ2-index = 1.496  10–8 
Ca0.78  Mg–0.30  Ox0.91  Cit–0.17 (4)
where Ca, Mg, Ox, and Cit concentrations
were expressed in mmol/L.
Results
The composition of stones determined
by infrared spectrophotometry is listed in
Table 1. Eleven patients had pure cal-
cium oxalate (CaOx) stones (calcium oxa-
late monohydrate (COM), CaC2O4 · H2O,
and/or calcium oxalate dihydrate (COD),
CaC2O4 · 2H2O) and fifteen patients had
mixed oxalate/phosphate stones with CaOx
(COM and/or COD) as major components
and apatitic calcium phosphates (Ap) as
minor components. The composition and
structure of apatitic calcium phosphates
(Ap) is similar to stoichiometric calcium
hydroxyapatite (Ca10(PO4)6(OH)2) in which
different ions (i.e., HPO42–, CO32–, F–, Mg2+,
Na+) are structurally incorporated.
Patients and controls did not differ
significantly in age and anthropometric
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TABLE 1





Calcium oxalate monohydrate (COM)





Sum I: Oxalate stones 11 42
COM + Apatitic calcium phosphates (Ap)





Sum II: Mixed oxalate and apatite stones 15 58
Total sum = Sum I + Sum II 26 100
parameters (Table 2). The dietary intake
of calcium was significantly lower in pa-
tients than in controls (p<0.01).
The mean concentrations of all param-
eters determined in the blood serum were
in the range of reference values and were
not significantly different in the groups of
patients and controls (Table 3). Slightly
increased levels of calcium and alkaline
phosphatase were found in the serums of
three patients.
The mean concentrations of all param-
eters determined in fasting first morning
urine (Table 4) were in the range of refer-
ence values and were not significantly
different for patients and controls. From
calcium, oxalate, citrate, and magnesium
concentrations in the fasting first morn-
ing urines, hypercalciuria (c(Ca) > 3
mmol/L)30 was determined for seven pa-
tients and three controls, hyperoxaluria
(c(Ox) > 0.3 mmol/L)30 for fourteen pa-
tients and eight controls, hypocitraturia
(c(Cit) < 0.7 mmol/L)31 for nine patients
and six controls, and hypomagnesiuria
(c(Mg) < 1 mmol/L)31 for one patient and
two controls. (The concentrations of Ca
and Ox, used as criteria for determina-
tion of hypercalciuria and hyperoxaluria,
respectively, were taken after ref. 30, and
concentrations of Cit and Mg for hypocit-
raturia, and hypomagnesiuria, respecti-
vely, were taken after ref. 31).
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TABLE 2
AGE, ANTHROPOMETRIC PARAMETERS,
AND DAILY DIETARY INTAKE OF CALCIUM






Age (years) 39.16.2 35.07.1
Height (cm) 174.55.7 180.55.8




a Significantly different, p<0.01 (t-test).
TABLE 3




Creatinine (ìmol/L) 96.218.1 91.57.3
Urea (mmol/L) 5.31.7 5.41.0
Alkaline phosphatase (U/L)a 153.753.7 128.625.2
Calcium (mmol/L) 2.30.1 2.40.1
Phosphorus (mmol/L) 0.90.2 1.10.2
Magnesium (mmol/L) 0.850.07 0.840.12
Sodium (mmol/L) 141.83.1 140.44.1
Potassium (mmol/L) 4.30.2 4.30.3
Chloride (mmol/L) 101.35.8 100.13.6
Cholesterole (mmol/L) 5.31.1 5.80.9
Trigliceride (mmol/L) 2.71.7 2.21.1
Proteins (g/L) 77.719.2 70.417.7
Urate (mol/L) 325.079.9 338.066.0
a U is enzyme unit.
Two patients had three metabolic dis-
orders (hypercalciuria, hyperoxaluria,
and hypocitraturia). Four patients had
two disorders (two of them had hypercal-
ciuria and hyperoxaluria, and two had
hyperoxaluria and hypocitraturia). It is
important to note that two of the patients
had very low oxalate concentrations (0.05
and 0.07 mmol/L) and another two very
low calcium concentrations (0.70 and 0.90
mmol/L) because of their restricted diet,
including high fluid intake.
Two controls had three metabolic ab-
normalities (one of them had hypercalciu-
ria, hyperoxaluria, and hypocitraturia,
and one had hyperoxaluria, hypocitratu-
ria, and hypomagnesiuria). Three con-
trols had two disorders (one of them had
hypercalciuria and hyperoxaluria, one had
hyperoxaluria and hypocitraturia, and
one had hypocitraturia and hypomagne-
siuria).
The mean values of parameters deter-
mined in 24-h urine (daily urine, DU) we-
re inside reference values32, but patients
with urolithiasis had significantly higher
calcium excretion (p<0.01) and signifi-
cantly lower potassium excretion (p<
0.01) compared to the controls (Table 5).
All other 24-h urine parameters did not
show significant differences between pa-
tients and controls. Hypercalciuria (Ca >
7 mmol/DU)32 was determined for seven
patients and two controls and hypomag-
nesiuria (Mg < 3 mmol/DU)31,33 for five
patients and four controls. (Concentra-
tion of Ca used for determination of hy-
percalciuria was taken after ref. 32, and
concentration of Mg for hypomagnesiuria
was taken after refs. 31 and 33). The con-
centrations of oxalate and citrate were
not measured in the 24-h urines. Urinary
infection was detected in urines of seven
patients.
The mean value of IAP(CaOx) calcula-
ted for first morning urines (Eqn. 1) was
higher for patients than for controls, but
the values were not significantly differ-
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TABLE 4




MeanSD R (parameter/creatinine)a MeanSD
R (parameter/
creatinine)a
Volume (mL) 298.2100.9 349.4147.8
pH 5.820.52 5.430.54
Creatinine (mmol/L) 15.76.0 14.75.6
Calcium (mmol/L) 2.281.13 1.390.67 1.921.32 1.160.65
Phosphorus (mmol/L) 17.42.8 10.93.5 17.74.0 11.73.7
Magnesium (mmol/L) 2.61.6 1.50.6 2.81.5 1.70.8
Sodium (mmol/L) 99.240.9 63.735.0 100.173.9 61.939.8
Potassium (mmol/L) 31.213.8 18.56.7 37.117.1 20.85.9
Oxalate (mmol/L) 0.370.26 0.220.12 0.320.18b 0.220.19
Citrate (mmol/L) 1.531.22 0.920.85 1.561.24 0.990.74
Urate (mmol/L) 2.571.08 1.500.46 2.511.49 1.440.49
a Ratio of corresponding parameter and creatinine calculated for each subject and expressed
as mean±SD, in mmol/g.
b Mean of N=16.
ent (Table 6). Also, the mean values of Ti-
selius indexes (Eqns. 2 and 3) and Ogawa
index (Eqn. 4) for patients and controls,




The patients and controls were well
matched with respect to sex, age, height,
and weight (Table 2). As a result of dieta-
ry calcium restrictions to which patients
were submitted, stone-formers participa-
ting in our study had significantly lower
calcium intake than healthy controls.
However, recent literature data indicate
that significantly lower dietary calcium
intake could expose the patients to a hig-
her risk for recurrence of calcium oxalate
urinary stones34, because an insufficient
supply or low availability of calcium for
complexation with oxalate in the intesti-
nal lumen could increase oxalate excre-
tion35. Therefore, it has been strongly rec-
ommended that dietary calcium intake
should not be restricted for calcium oxa-
late stone-formers36.
The 24-hour urine is usually used for
metabolic evaluation of stone formers,
but the long-term storage of 24-h urine
and the use of different additives might
destroy or alter important urine constitu-
ents. The reliability of urines collected in
different time intervals (i.e., fasting first
morning urine, 8-h urine, and 16-h uri-
nes) in the clinical evaluation of stone for-
mers was the objective of several recent
studies37–39. It was found that 16-h and
8-h urines collected during the day and
night, respectively, are reliable speci-
mens for determination of metabolic ab-
normalities37. Moreover, the urinary Ca,
Ox, and Cit concentrations, as well as the
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TABLE 5
24-HOUR URINE PARAMETERS FOR UROLITHIASIS PATIENTS (N=26) AND CONTROLS (N=18)
Patients Controls
Parameter
MeanSD R (parameter/creatinine)a MeanSD
R (parameter/
creatinine)a
Volume (mL) 1482.0545.2 1452.0154.3
pH 5.60.7 5.50.6
Creatinine (mmol/DU)b 16.42.4 17.54.1
Calcium (mmol/DU) 5.62.5c 3.01.3 c 3.71.9 2.40.8
Phosphorus (mmol/DU) 32.310.2 17.34.3 33.112.2 16.64.3
Magnesium (mmol/DU) 4.11.7 2.20.8 4.21.2 2.20.6
Sodium (mmol/DU) 190.670.6 104.338.8 220.080.3 109.727.2
Potassium (mmol/DU) 49.215.7c 27.19.8 c 74.533.8 36.211.2
Chloride (mmol/DU) 196.863.6 108.337.9 236.777.0 118.731.5
Urea (mmol/DU) 393.475.9 213.840.4 419.694.4 214.137.8
Urate (mmol/DU) 3.60.9 1.90.5 3.71.4 1.80.4
Proteins (g/DU) 0.250.24 1.140.13 0.160.04 1.070.07
a Ratio of corresponding parameter and creatinine calculated for each subject and expressed
as mean±SD, in mmol/g.
b DU = daily urine (24-h urine).
c Significantly different, p<0.01 (t-test), from the corresponding value for controls.
creatinine-corrected Ca, Ox, Cit, and Mg,
showed a significant correlation between
early morning spot urine and 24-h urine
specimens39. The mean values of creatini-
ne-corrected parameters for Ca, P, Mg,
Na, and K (parameter/creatinine ratios)
determined in fasting first morning urine
and 24-h urine (Tables 4 and 5, respecti-
vely) in this study, also showed signifi-
cant correlation; all parameters were sig-
nificantly higher in 24-h urine than in
fasting first morning urine for the group
of patients as well as for the group of con-
trols.
The mean concentrations of Ca and
corresponding Ca/creatinine ratios in fas-
ting first morning urines and 24-h urines
were higher for patients than for controls,
but the differences were significant (p<
0.01) only in the 24-h urine (Table 5). Hig-
her calcium excretion for calcium oxalate
stone-formers is in agreement with previ-
ous studies5–10,37–39.
Significantly lower potassium excre-
tion was determined in 24-h urines of stone-
formers (Table 5). This result is in accor-
dance with literature data1 that indicated
nutritional deficiency of potassium as a
risk factor for stone formation. In addi-
tion, a significant increase in potassium
was found in the urines of the recurrent
stone formers that were recurrence-free
after specific therapy40.
The lack of statistically significant dif-
ferences (determined by the parametric
t-test) between patients and controls for
all urine parameters except calcium and
potassium in 24-h urine could not be con-
tributed to the possible non-Gaussian
distributions. Namely, the non-paramet-
ric Mann-Whitney test that does not as-
sume that the difference between two in-
dependent populations has normal (Gau-
ssian) distribution confirmed the t-test
data. Therefore, the non-significant diffe-
rences between urine parameters for pa-
tients and controls could be partly explai-
ned by (a) the small sizes of patient and
control groups, (b) presence of relatively
large number of controls with metabolic
disorders (i.e., hyperoxaluria and hyper-
calciuria were determined in fasting first
morning urines for seven and three con-
trols, respectively), and (c) presence of pa-
tients that were on restricted diet/high
fluid regiment (i.e., extremely low cal-
cium and/or oxalate concentrations were
determined in fasting first morning urine
of four patients).
Influence of Mg and Cit concentrations
on IAP(CaOx)
The calculated mean value of IAP(CaOx)
in fasting first morning urine, which is an
indication of urine saturation with res-
pect to calcium oxalate formation, was
higher (but not significantly) for the group
of patients. In general, higher concentra-
tions of calcium and oxalates would in-
crease IAP(CaOx) values, whereas higher
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TABLE 6
IONIC ACTIVITY PRODUCTS, IAP(CaOx), AND TISELIUS AND OGAWA INDEXES CALCULATED







108 IAP(CaOx) 2.01.5 1.61.4
AP(CaOx)-index (Tiselius) 18.218.3 12.219.3
lmult1CaOx-risk-index, RI (Tiselius) 277214 287213
108  AP(CaOx)-EQ2-index (Ogawa) 8.76.1 6.94.9
concentrations of citrates, magnesium,
phosphorus (phosphates), sodium, and po-
tassium would decrease the IAP(CaOx)
values. Citrate and phosphate form com-
plex species with calcium, causing a dec-
rease in the free Ca2+ activity, whereas
magnesium, sodium, and potassium form
complex species with oxalates causing a
decrease in the activity of free Ox2– (Tab-
le 7).
Very high and very low urinary con-
centrations of citrate and magnesium gi-
ve different values of IAP(CaOx) (Table 7)
calculated for a hypothetical urine having
concentrations of all parameters (except
Cit and Mg) equal to the mean values de-
termined in the fasting first morning uri-
ne of the patients in this study (Table 4).
The maximum and minimum Cit and Mg
concentrations determined in the fasting
urines of the patients were used in the
calculations (Table 4) and the calculated
Ca and Ox speciation and the correspond-
ing IAP(CaOx) values are listed in Table
7. It is seen that for maximum and mini-
mum Cit concentrations, the mol frac-
tions of CaCit– complexes are 35.6 % and
9.0 %, and the mol fractions of free Ca2+
49.6 % and 67.4 %, respectively. For max-
imum and minimum Mg concentrations
the mol fractions of MgOx0 complexes are
47.8 % and 9.9 %, and the mol fractions of
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TABLE 7
CONCENTRATIONS AND MOL FRACTIONS OF CALCIUM AND OXALATE SPECIES, ACTIVITIES OF
CALCIUM AND OXALATE IONS, AND IONIC ACTIVITY PRODUCTS, IAP(CaOx), CALCULATED USING
THE MEAN PARAMETERS OF PATIENTS FASTING URINE (LISTED IN TABLE 4) AND (A) HIGH AND
(B) LOW CITRATE (CIT) AND MAGNESIUM (MG) CONCENTRATIONS
(a) High Cit and Mg
c(Cit)=5 mmol/L,
c(Mg)=9.0 mmol/L























































































free Ox2– 28.1 % and 45.4 %, respectively.
Consequently, for maximum and mini-
mum Cit and Mg, the IAP(CaOx) values
are 1.2  10–8 and 2.8  10–8, respectively,
i.e. about ten times higher concentration
of Mg in concert with about ten times hig-
her concentration of Cit reduced the IA-
P(CaOx) value for about two times only,
which indicates that the influence of Cit
and Mg ions on the saturation level of uri-
ne is not very dramatic. However, the role
of Cit and Mg in urines should not be un-
derestimated, since besides reduction of
saturation, Cit and Mg are also potent in-
hibitors of CaOx crystallization.
Correlation between IAP(CaOx)
and risk indices
The IAP(CaOx) values calculated for
patients and controls were correlated
with the values of corresponding indices:
AP(CaOx)-index (Tiselius) (Figure 1),
CaOx-risk-index, RI (Tiselius) (Figure 2),
and AP(CaOx)-EQ2-index (Ogawa) (Figu-
re 3). All correlations were significant.
The strongest correlation and the highest
correlation coefficient (r=0.97) was deter-
mined for IAP(CaOx) vs. AP(CaOx)-EQ-
index (Ogawa). This result indicates that
the empirical exponents for Ca, Mg, Ox,
and Cit concentrations in the equation for
AP(CaOx)-EQ2-index (Ogawa) are very
well estimated. The values of IAP(CaOx)
and Ogawa index were extremely low for
two patients and extremely high for three
controls (Figure 3). These two patients
had very low urinary Ox concentrations
and the three controls had very high uri-
nary Ox and/or Ca concentrations.
Determination of IAP(CaOx) or the
Ogawa index in different urine samples
could be a good indication for the risk of
calcium oxalate urolithiasis35, but deter-
mination of other parameters, such as the
total inhibitory activity of urines, partic-
ularly with respect to macromolecular
urine fractions12,14,15, should improve dis-
crimination between stone-formers and
healthy individuals. Some simple, clini-
cally applicable methods for the determi-
nation of the inhibitory activity of urines
with regard to calcium oxalate precipita-
tion41–43 and its calcium binding capaci-
ty44 have been proposed and one of them41
has been successfully used in the follow-
up of the therapy of patients with recur-
rent urolithiasis45. Such alternative ap-
proach to the prophylaxis and treatment
of recurrent urolithiasis seems to have
great potential.
Conclusions
The concentration of calcium was sig-
nificantly higher and concentration of po-
tassium was significantly lower in the
24-h urines of calcium oxalate stone-for-
mers as compared to healthy controls.
Very strong correlation (r=0.97) was ob-
tained between IAP(CaOx) values and
calculated Ogawa indices that were rec-
ommended for estimating the potential
risk for calcium oxalate stone formation.
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METABOLI^KA EVALUACIJA ISPITANIKA S UROLITIJAZOM
IZ ISTO^NE HRVATSKE
S A @ E T A K
Metaboli~ki su parametri odre|eni u krvnom serumu, prvom jutarnjem urinu i 24-
satnom urinu 26 mu{karaca (dob 39.1±6.2 god.) s recidiviraju}im kalcij-oksalatnim
mokra}nim kamencima, te u urinu 18 zdravih mu{karaca (dob 35.0±7.1 god.), iz is-
to~nog dijela Hrvatske. Izlu~eni kalcij u 24-satnim urinima pacijenata (5.6±2.5 mmol)
je zna~ajno ve}i (p<0.01) nego u zdravih osoba (3.7±1.9 mmol), dok je izlu~eni kalij ve}i
(p<0.01) u urinima zdravih osoba (74.5±33.8 mmol) nego u pacijenata (49.2±15.7 mmol).
Srednji ionski aktivitetni produkti kalcija i oksalata, IAP(CaOx), ra~unati iz kemijskog
sastava prvog jutarnjeg urina, 25 % su ve}i za pacijente nego za zdrave osobe, ali ta
razlika nije statisti~ki zna~ajna (p>0.05). Utvr|ena je vrlo dobra korelacija izmedju
IAP(CaOx) vrijednosti i izra~unatih Ogawinih indeksa, koji su pokazatelji rizika za
stvaranje kamenaca kalcijevog oksalata.
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